Arcus Biosciences Announces New Employment Inducement Grants

first_img Twitter Arcus Biosciences Announces New Employment Inducement Grants Local NewsBusiness By Digital AIM Web Support – February 9, 2021 WhatsApp Facebook Twitter HAYWARD, Calif.–(BUSINESS WIRE)–Feb 9, 2021– Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that the Compensation Committee of the Company’s Board of Directors granted five new employees options to purchase a total of 126,200 shares of the Company’s common stock at an exercise price per share of $41.39, which was the closing price on February 8, 2021. The stock options were granted pursuant to the Company’s 2020 Inducement Plan, which was approved by the Company’s Board of Directors in January 2020 pursuant to the “inducement exception” under NYSE Listed Company Manual Rule 303A.08. About Arcus Biosciences Arcus Biosciences is an oncology-focused biopharmaceutical company leveraging its deep cross-disciplinary expertise to discover highly differentiated therapies and to develop a broad portfolio of novel combinations addressing significant unmet needs. Arcus currently has four molecules in clinical development: Etrumadenant (AB928), the first dual A 2a /A 2b adenosine receptor antagonist to enter the clinic, is being evaluated in multiple Phase 2 and 1b studies across different indications, including prostate, colorectal, non-small cell lung, pancreatic and triple-negative breast cancers. AB680, the first small-molecule CD73 inhibitor to enter the clinic, is in Phase 1/1b development for first-line treatment of metastatic pancreatic cancer in combination with zimberelimab and gemcitabine/nab-paclitaxel. Domvanalimab (AB154), an anti-TIGIT monoclonal antibody and new potential immuno-oncology backbone therapy, is in a three-arm randomized Phase 2 study for first-line treatment of PD-L1-high metastatic non-small cell lung cancer (NSCLC) evaluating zimberelimab monotherapy, domvanalimab with zimberelimab and domvanalimab plus AB928 with zimberelimab. In addition, domvanalimab is advancing into ARC-10, Arcus’s “two in one trial” to support the potential approvals of both zimberelimab and zimberelimab + domvanalimab and a registrational study, in collaboration with AstraZeneca, evaluating the curative-intent stage III NSCLC setting. AB308, an anti-TIGIT antibody that is FcR enabled, is advancing into clinical development to investigate additional indications, with a focus on hematological malignancies. Zimberelimab (AB122), Arcus’s anti-PD-1 monoclonal antibody, was in-licensed to enable the development of Arcus’s combination regimens and is being evaluated in various combinations across the portfolio. For more information about Arcus Biosciences, please visit www.arcusbio.com. Inducement PR Source: Arcus Biosciences View source version on businesswire.com:https://www.businesswire.com/news/home/20210209005848/en/ CONTACT: Katherine Bock VP Investor Relations & Corporate Strategy (510) 694-6231 [email protected] KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY PHARMACEUTICAL HEALTH ONCOLOGY SOURCE: Arcus Biosciences, Inc. Copyright Business Wire 2021. PUB: 02/09/2021 04:10 PM/DISC: 02/09/2021 04:11 PM http://www.businesswire.com/news/home/20210209005848/encenter_img Previous articleBlue Jackets C Mikko Koivu retires during 16th NHL seasonNext articlePrimerica Reports Fourth Quarter 2020 Results Digital AIM Web Support TAGS  WhatsApp Facebook Pinterest Pinterestlast_img read more

Read more on Arcus Biosciences Announces New Employment Inducement Grants

Garden veggies safe?

first_imgThese are the most important safeguards you can use in thegarden. Keep in mind, though, that food safety begins in thegarden but doesn’t end there.In the kitchenWhen you prepare fruits and veggies to eat, don’t forget to usethe kitchen faucet. Hand-scrub firm produce such as apples,pears, tomatoes and bell peppers under running water.Spray root vegetables and tubers with water, scrub them with avegetable brush and then rinse them.Wash vegetables with rinds, such as watermelons and cantaloupes,too. If the surface isn’t clean, you can transfer bacteria to theflesh when you cut them.No one should get sick from eating produce from your garden. Youcan make sure they won’t by using good sanitation and followingsound gardening practices.Enjoy your garden produce. But remember, the best food safety inthe world can’t protect you from the ills of overindulgence.(Darbie Granberry is an Extension Service horticulturist withthe University of Georgia College of Agricultural andEnvironmental Sciences.) Use good personal hygiene.Don’t apply manure to your garden.Keep animals out of your garden.Use only drinking-quality water for irrigation.Use clean containers when you harvest. By Darbie GranberryUniversity of GeorgiaAlmost anything can make us sick, including pure water, if weconsume too much at one time. But what about the seriousillnesses we normally call “food poisoning”?The biggest fear has always been getting food poisoning frommeats. In the past few years, though, we’ve found that improperlygrown, packed or shipped fresh fruits and vegetables can lead toserious illness, too.Can vegetables from our own gardens make us sick? Possibly, ifthey’re contaminated with human pathogens such as hepatitis A,Salmonella and E. coli 0157:H7.The good news is that the chance of anyone in the United Statesgetting sick from garden vegetables is remote. Human pathogensdon’t occur naturally on vegetables.Safety keySo how do people sometimes get sick from eating produce?Contamination, contamination, contamination.Whenever produce is grown, packed or shipped under poor sanitaryconditions, there’s always the chance it will be contaminated andbecome a health hazard.The November 2003 outbreak of hepatitis A is a prime example.Green onions harboring the hepatitis virus caused more than 600illnesses and three deaths in Pennsylvania.The Centers for Disease Control and Prevention estimates thereare 76 million foodborne illnesses a year in the United States.Every year more than 325,000 people are hospitalized and 5,000people die from eating contaminated food.As you might guess, the greatest concern is for the fruits andvegetables you eat raw as snacks and in salads. Some scientistslink nearly as many foodborne illness cases to produce as topoultry, beef and fish combined.Simple stepsTo make sure no one gets sick from eating fruits and vegetablesfrom your garden:last_img read more

Read more on Garden veggies safe?

Indonesia reports 100th human H5N1 case

first_imgJun 15, 2007 (CIDRAP News) – Indonesia’s toll of people struck by H5N1 avian influenza has risen to 100, including 80 deaths, with the report that a 26-year-old man from Sumatra died of the disease on Jun 12.The Indonesian health ministry said the man from Riau province fell ill on Jun 3 and was hospitalized Jun 6, according to a World Health Organization (WHO) statement today. Investigators found he had been exposed to sick and dead poultry, the statement said.The case pushed the WHO’s global H5N1 count to 313 cases with 191 deaths. However, four cases reported recently by Vietnam have not yet been confirmed by the WHO.An Agence France-Presse (AFP) report on the Sumatra man’s case yesterday differed from the WHO statement in some details. The story, quoting a hospital official, listed his age as 29 and said he had been hospitalized Jun 11 after being sick for a week.The hospital official, Azizman Daan, told AFP the man had slaughtered and cooked a sick chicken after 3 of his 5 chickens died.Indonesia’s first human H5N1 illness cases were reported in July 2005. The country only recently surpassed Vietnam for having the greatest number of cases. By the WHO count, Vietnam has had 93 cases and 42 deaths.See also:Jun 15 WHO statementhttp://www.who.int/csr/don/2007_06_15/en/index.htmllast_img read more

Read more on Indonesia reports 100th human H5N1 case

Indonesia’s COVID-19 cases top 100,000 as Jakarta logs new daily record

first_imgThe city’s previous daily highs include 441 new cases on July 21, 404 on July 12, 395 on July 11 and 344 on July 8.Behind Jakarta is East Java, which reported 273 new cases on Monday, followed by Central Java with 210 cases, South Sulawesi with 110 cases and Bali with 62 cases.The new cases brought the total number of confirmed cases in East Java – home to some 39 million people – to 20,812, the highest among the country’s 34 provinces to date.Indonesia has recorded the highest number of confirmed COVID-19 cases in Southeast Asia, with its official tally having also surpassed the official tallies of South Korea, Japan and China.A Flourish chart As of Monday, Indonesia’s death toll from the contagious respiratory illness had reached 4,838, with 1,608 deaths recorded in East Java, followed by Jakarta with 769 and Central Java with 574.According to the COVID-19 task force, East Java’s provincial capital of Surabaya has logged the single-largest number of coronavirus-related fatalities in the country of 268 million people.The task force’s latest COVID-19 data analysis as of Saturday found that the city had recorded more than 800 deaths linked to COVID-19.Other regions with the highest numbers of COVID-19-related fatalities include Semarang in Central Java, with at least 250 deaths, Makassar in South Sulawesi with at least 211 deaths, Central Jakarta with at least 180 deaths and East Jakarta with at least 156 deaths, the report showed.Furthermore, Surabaya had also recorded the country’s highest mortality rate of 27.22 per 100,000 people at the time of the writing.Other regions with the highest COVID-19 mortality rates include Banjarmasin in South Kalimantan (18.20), Manado in North Sulawesi (18.20), Palangkaraya in Central Kalimantan (17.94), and Semarang in Central Java (16.96), according to the report.Topics : Indonesia’s official tally of COVID-19 cases has reached 100,303 after the government recorded 1,525 new infections on Monday, with Jakarta reporting its highest one-day spike since the first confirmed cases were detected in the city in March.The capital recorded 467 new confirmed cases on Monday, bringing the total number of confirmed cases in the city of 10 million people to 19,592.The latest figures continue the trend of increasing numbers of confirmed cases in Jakarta in recent weeks following the city’s decision to gradually relax restrictions and reopen businesses and offices under health protocols from June 4.last_img read more

Read more on Indonesia’s COVID-19 cases top 100,000 as Jakarta logs new daily record

ING Investment Management poaches convertible bond team from rival

first_imgHans Stoter, the asset manager’s CIO, said he expected to focus on yield, low volatility and limited downside risk in the current investment climate.“Convertible bonds fit very well within this environment and provide an excellent complementary strategy to our product suite,” he added.Stoter praised Saber and Van Ingen as “seasoned investment experts”.Saber has nearly 30 years’ experience in the convertible bond market, launching APG’s corporate opportunity strategy fund.He has also worked at HSBC Investment Bank as its global head of convertible bonds and was head of European convertible bonds at Schroder Securities.For his part, Van Ingen spent six years at APG working on the corporate opportunity strategy fund launched by Saber, but also as a hedge fund portfolio manager in APG’s New York office.Both will be based in London. ING Investment Management has poached the team in charge of a rival convertible bond vehicle, growing its range of funds.Tarek Saber, whose move to ING IM was confirmed last week, will be joined at the asset manager by Jasper van Ingen.Both joined previous employer Avoca in 2011 from Dutch civil service scheme APG.They joined ING IM in November – Saber as investment team manager for convertible bonds, Van Ingen as senior portfolio manager for convertible bonds.last_img read more

Read more on ING Investment Management poaches convertible bond team from rival

Fruta, Timehri and Buxton rampant as quarter-final spots booked

first_imgTHE last eight of the KFC Independence National Under-20 Football tournament has been decided, with Fruta Conquerors, Timehri Panthers and Buxton United turning in the most eye-catching performances in the Round-of-16 held over the weekend at the National Training Centre, Providence.Conquerors tamed Cougars 8-0 courtesy of a Nicholas McArthur helmet-trick while Reshaun Ritch, Simeon Hackett, Nicolai Andrews and Leon Richardson were also on the score sheet.Meanwhile, Soesdyke Falcons were grounded by Panthers, losing 1-5. Goals were struck by Tyrone Khan (14th), Shawn Steele (20th), Tyrone Burnette (47th), Shoron James (66th) and Shanon Samnauth (70th), while Jonathan Bailey netted the only goal for the losers in the 45th minute.Botofago FC of Linden came from a goal down to beat Den Amstel FC of West Demerara 4-2. Anthony Benn scored for the West Demerara unit in the 40th and 80th minutes, but strikes from Andre Mayers (45th), (52nd), (64th) and (90+2) delivered the comeback.A brace from John Gonsalves led Dynamic FC of East Coast Demerara to a 5-0 mauling of Potaro Strikers from Bartica.New Amsterdam United FC and Amelia’s Ward FC of Linden produced a tight game with the Berbice outfit coming out 1-0 winners courtesy of Keon Williams in the 47th minute.Santos knocked out West Demerara’s Pouderoyen FC with a 3-1 win as Ronaldo Rodrigues (5th), Ryan Dowding (33rd) and Randy Roberts (47th) hit the back of the net for the winners, while Stephon Jupiter scored in the 47th for the losing side.Panthers will face Botofago, and Dynamic FC will come up against Amelia’s Ward in the first set of quarter-finals, followed by Conquerors against Buxton United and Santos versus Strikers FC, who drew a bye in the Round-of-16.The quarter-finals will be held this Saturday and Sunday. First place will collect $500 000, second $300 000, third $200 000 and fourth a trophy.last_img read more

Read more on Fruta, Timehri and Buxton rampant as quarter-final spots booked